An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 80
Updated:2/1/2019
Start Date:August 14, 2018
End Date:March 21, 2019
Contact:Recruiting sites have contact information. Please contact the sites directly. If there is no contact information,
Email:Clinical.Trials@bms.com
Phone:please email:

Use our guide to learn which trials are right for you!

A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BMS-986224 in Participants With Varying Degrees of Renal Function

The purpose of this study is to investigate the experimental medication BMS-986224 in
participants with varying levels of renal function.


For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com

Inclusion Criteria:

- BMI ≥18 and ≤ 35kg/m2

- Systolic blood pressure >100 mmHg

Exclusion Criteria:

- Women of childbearing potential or women who are currently pregnant

- Clinically relevant abnormal medical history, abnormal findings on physical
examination, vital signs, ECG, or laboratory tests at screening that the investigator
judges as likely to interfere with the objectives of the trial or the safety of the
volunteer

- Current or recent (within 3 months of study treatment administration) gastrointestinal
disease that could affect absorption

Other protocol defined inclusion/exclusion criteria could apply
We found this trial at
4
sites
Saint Paul, Minnesota 55114
Phone: 651-641-2900
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
407-240-7878
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Knoxville, Tennessee 37920
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
Miami, Florida 33014
Phone: 305-817-2900
?
mi
from
Miami, FL
Click here to add this to my saved trials